OBGYN & Reproduction Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN & Reproduction Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Sexual Dysfunction
Pfizer to end tests of Viagra for women
March 15th, 2004
Pfizer Inc. is ending research on whether the anti-impotency drug Viagra can be used treat female sexual problems because studies on women were inconclusive, the company said. The results of several clinical studies involving about 3,000 women did not support a regulatory filing, Pfizer said February 27, 2004. Karen Katen, executive vice president of Pfizer and president of Pfizer Global Pharmaceuticals, said that while the company was disappointed that the program was not more successful, "this is the nature of drug development." "We make substantial financial investments, marshal the talents of our best scientists and...
Source: OBGYN & Reproduction Week (2004-03-15)
|
